Using Etomidate in a Two-month-old Infant with Cushing Syndrome due to Adrenocortical Carcinoma

Cushing syndrome (CS) is a rare disease caused by hypercortisolemia. Although surgical treatment is the first-line treatment in CS, the appropriate medication for the patient's condition should be selected when medical treatment is needed. Etomidate is an adrenal-blocking drug used to treat CS...

Full description

Bibliographic Details

Published in:	JCRPE
Main Authors:	Ahreum Kwon, youngha choi, Jo Won Jung, Junghwan Suh, Ho-Seong Kim
Format:	Article
Language:	English
Published:	Pediatric Endocrinology and Diabetes Society 2022-03-01
Subjects:	etomidate infant cushing syndrome
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=jcrpe&un=JCRPE-47966